CareCloud, Inc.

CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.

CareCloud Inc

CareCloud, Inc. (NASDAQ:CCLD ) Q3 2024 Earnings Call Transcript November 12, 2024 8:30 AM ET Company Participants Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - Chief Executive Officer Stephen Snyder - President Norman Roth - Chief Financial Officer and Corporate Controller Crystal Williams - Chief Operating Officer Conference Call Participants Destiny Hance - Ladenburg Hulman Allen Klee - Maxim Group Operator Greetings. And welcome to the CareCloud Inc. Third Quarter 2024 Results Conference Call.

CareCloud, Inc. (CCLD) Q3 2024 Earnings Call Transcript

Pays Off Credit Line, Plans to Resume Preferred Dividends in Q1 2025 SOMERSET, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced financial and operational results for the quarter ended September 30, 2024 including that it has fully paid its credit line and that it plans to resume dividends on its Series A and B Preferred Stock on March 15, 2025.

CareCloud Reports Third Quarter 2024 Results

SOMERSET, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc . (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced a strategic partnership with ChartSwap, a leading provider of business-to-business (B2B) medical and billing records exchange, to launch "CareCloud Powered by ChartSwap.” This new collaboration will significantly enhance the way medical records are handled and accessed, enabling CareCloud's providers to focus more on delivering high-quality patient care.

CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process

SOMERSET, N.J., Sept. 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc . (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today reconvened its special meeting (“Special Meeting”) of CareCloud's Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) shareholders. At the Special Meeting, shareholders representing more than two-thirds of the outstanding shares of Series A Preferred Stock approved the preferred stock proposal, which included an amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”).

CareCloud Announces Approval of Series A Preferred Stock Proposal

SOMERSET, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 89% of the shares represented by proxies returned to-date for the Series A Preferred Stock special meeting (“Special Meeting”) have indicated that they are voting “FOR” the amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”). Due to the significantly narrowed gap for passage of the Preferred Stock Proposal, the Special Meeting will be reconvened on Wednesday, September 11, 2024 at 11:00 a.m. Eastern Time.

Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th

CareCloud, Inc. (NASDAQ:CCLD ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - CEO Stephen Snyder - President Norman Roth - Interim CFO and Corporate Controller Conference Call Participants Allen Klee - Maxim Group Operator Ladies and gentlemen, welcome to the CareCloud Second Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.

CareCloud, Inc. (CCLD) Q2 2024 Earnings Call Transcript

SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended June 30, 2024 before the market opens on Tuesday, August 13, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024

SOMERSET, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the “Series A Preferred Shareholders”) of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of its' Series A Preferred Stock (the “Preferred Stock Proposal”). With approximately 20% of the shares of Series A Preferred Stock having already returned their proxies, 82% of these shares (up from 72% last week) are in favor of the changes recommended in the Preferred Stock Proposal.

Voting on CareCloud's Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal

SOMERSET, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it has begun soliciting proxies from the holders (the “Series A Preferred Shareholders”) of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Preferred Stock Proposal”). Under the Preferred Stock Proposal, holders of Series A Preferred Stock would receive similar change of control protections to those afforded to holders of the Company's 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”). The future dividends of the Series A Preferred Stock would mirror that of the Series B Preferred Stock, and the Company would, going forward, have the right to exchange the shares of Series A Preferred Stock for shares of common stock at the liquidation preference value of $25 per share, plus any accrued and unpaid dividends.

CareCloud Proposes Amendment to the Terms of its Series A Preferred Stock

SOMERSET, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2024 Annual Shareholders' Meeting on June 17, 2024, during which the shareholders, by an overwhelming majority, reelected all four director nominees.

CareCloud Announces Results from Annual Shareholder Meeting

Focus on Enhancing Profitability and Further Streamlining Operations SOMERSET, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc.  (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the promotion of Crystal Williams as its new chief operating officer with the goal of further streamlining operations and supporting the Company's achievement of its profitability and free cash flow objectives.

CareCloud Promotes Crystal Williams to Chief Operating Officer

SOMERSET, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today released details regarding its receipt of an unsolicited, non-binding indication of interest dated March 4, 2024, to acquire the Company for $5.00 per share of its common stock, and the $25 redemption price per share of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”). The indication of interest was subject to satisfactory due diligence.

CareCloud Capital Structure Update

SOMERSET, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it has retained Citizens JMP as its exclusive capital structure advisor.

CareCloud Retains Citizens JMP as its Exclusive Capital Structure Advisor

SOMERSET, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended March 31, 2024 before the market opens on Tuesday, May 14, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

CareCloud To Announce First-Quarter 2024 Results on May 14, 2024

SOMERSET, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, is pleased to announce its participation in the 2024 Kansas MGMA Annual Conference, taking place from April 17-19 at the Wichita Marriott, Kansas. CareCloud will seize this opportunity to showcase its innovative solutions aimed at transforming revenue cycle management (RCM) and enhancing patient engagement within the healthcare industry.

CareCloud to Showcase Cutting-Edge Healthcare Technology Solutions at the 2024 Kansas MGMA Conference

CareCloud, Inc. (CCLD) Q4 2023 Earnings Call Transcript

SOMERSET, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDP and CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced financial and operational results for the year ended December 31, 2023. The Company's management will conduct a conference call with related slides today at 8:30 a.m. Eastern Time to discuss these results and management's outlook for the year.

CareCloud Reports Full Year 2023 Results

SOMERSET, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its participation in the HIMSS Global Health Conference and Exhibition, taking place from March 11-15 in Orlando, Florida. Positioned at booth 5281, CareCloud will use this opportunity to showcase its state-of-the-art generative AI solutions, alongside its other products and services for physician practices.

CareCloud to Showcase its Generative AI Solutions and Tech-Enabled RCM at the 2024 HIMSS Conference and Exhibition

SOMERSET, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- CareCloud , Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its participation in the premier digital health event, ViVE 2024, which will be held at the Los Angeles Convention Center February 25th to February 28th, 2024. Located at booth V-844 at South Hall, CareCloud will showcase its cutting-edge solutions, including CareCloud Force, featuring advanced staff augmentation capabilities. The Company will showcase its award-winning Concierge-RCM service, including comprehensive revenue cycle management (RCM) support, and Wellness, a cornerstone of CareCloud's holistic healthcare approach.

CareCloud to Unveil Cutting-edge Healthcare Solutions at Vive 2024, Showcasing Innovation and Leadership in Digital Health

SOMERSET, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in health care technology solutions for medical practices and health systems nationwide, today announced that Pediatric Associates of Dayton, a practice managed by CareCloud, is now integrated into the Dayton Children's Hospital network.

CareCloud's Managed Practice Pediatric Associates of Dayton Joins Dayton Children's Network

Streamlining Operations and Enhancing Patient Care Through Innovative Health Tech Solutions SOMERSET, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in health care technology solutions for medical practices and health systems nationwide, today announced siParadigm, a visionary pathology practice, has chosen CareCloud Central , a robust practice management platform, to optimize operations and elevate the quality of patient care.

CareCloud Elevates Pathology Practice siParadigm with Cutting-Edge CareCloud Central Platform

SOMERSET, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in health care technology solutions for medical practices and health systems nationwide, today announced its participation in The Arab Health Exhibition and Congress, set to take place Jan. 29 to Feb. 1, 2024, at the Dubai World Trade Centre. The event, renowned for bringing together global healthcare influencers, professionals, and exhibitors, will serve as a platform for CareCloud to showcase its cutting-edge solutions.

CareCloud Takes Center Stage at The Arab Health Exhibition and Congress 2024

SOMERSET, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc.  (the “Company”) (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that its Board of Directors has suspended its monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") beginning with the payment scheduled for December 15, 2023. The suspension of these dividends will defer approximately $1.3 million in cash dividend payments each month. During this suspension, dividends will continue to accrue on the Series A and Series B Preferred Stock. The Board of Directors will regularly review and consider when the suspension should be lifted.

CareCloud Announces Suspension of its Dividends on Non-Convertible Series A and Series B Cumulative Redeemable Perpetual Preferred Stock

SOMERSET, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the launch of its redesigned and enhanced Therapy Solution Suite, a cutting-edge, all-in-one web-based solution poised to transform therapy and rehabilitation practice management by offering an unparalleled combination of financial, operational, and clinical efficiency.

CareCloud Launches Redesigned and Enhanced Comprehensive Solution for Rehabilitation and Therapy Practices

SOMERSET, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Justin Pierce as its new chief sales officer (CSO). In this role, Pierce will be responsible for driving sustainable revenue growth and enhancing CareCloud's position in the rapidly evolving healthcare landscape.

News for CareCloud, Inc. Stock (CCLDP)